Average one-year analyst price target for Xtant Medical (XTNT) was revised to $1.38, a 10.0% decrease from the prior $1.53 target dated Feb 21, 2026. The new $1.38 figure is the mean of multiple analyst targets, indicating modestly softened analyst sentiment; this is a notable analyst update but likely limited in broader market impact.
Average one-year analyst price target for Xtant Medical (XTNT) was revised to $1.38, a 10.0% decrease from the prior $1.53 target dated Feb 21, 2026. The new $1.38 figure is the mean of multiple analyst targets, indicating modestly softened analyst sentiment; this is a notable analyst update but likely limited in broader market impact.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly negative
Sentiment Score
-0.25
Ticker Sentiment
